Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2450 of 2529 entries
View as:

Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01338818 Org: User:
Start: 04/30/11 End: 02/28/13 Due: 02/28/14

Observation of Treatment Patterns With Lucentis in Approved Indications

Phase: N/A Priority: Normal
NCT ID: NCT02194803 Org: User:
Start: 12/08/11 End: 12/31/16 Due: 12/31/17

Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL)

Phase: N/A Priority: Normal
NCT ID: NCT04225676 Org: User:
Start: 10/19/20 End: 10/19/21 Due: 10/19/22

A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients

Phase: N/A Priority: Normal
NCT ID: NCT02649218 Org: User:
Start: 05/24/16 End: 05/02/19 Due: 05/02/20

Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00099944 Org: User:
Start: 05/31/04 End: 10/31/05 Due: 10/31/06

A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT06142383 Org: User:
Start: 12/12/23 End: 11/01/24 Due: 11/01/25

Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy.

Phase: N/A Priority: Normal
NCT ID: NCT00258765 Org: User:
Start: 05/31/06 End: - Due: -

Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00099242 Org: User:
Start: 11/30/03 End: 01/31/06 Due: 01/31/07

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

Phase: N/A Priority: Normal
NCT ID: NCT02947165 Org: User:
Start: 04/25/17 End: 06/18/21 Due: 06/18/22

A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01327053 Org: User:
Start: 06/29/11 End: 06/29/18 Due: 06/29/19

Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT00704483 Org: User:
Start: 07/31/08 End: - Due: -

Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications

Phase: N/A Priority: Normal
NCT ID: NCT04847895 Org: User:
Start: 06/01/15 End: 03/31/21 Due: 03/31/22

Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00106340 Org: User:
Start: 03/31/05 End: 05/20/08 Due: 05/20/09

Ribociclib (LEE011) Rollover Study for Continued Access

Phase: N/A Priority: Normal
NCT ID: NCT02934568 Org: User:
Start: 12/15/16 End: 09/01/26 Due: 09/01/27

Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT00698464 Org: User:
Start: 07/31/08 End: - Due: -

Efficacy, Safety, Tolerability and Pharmacokinetics of KAE609 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection

Phase: N/A Priority: Normal
NCT ID: NCT01524341 Org: User:
Start: 01/31/12 End: 06/30/12 Due: 06/30/13

Study to Demonstrate the Efficacy and Safety of Secukinumab up to 224 Weeks in Subjects With Active Peripheral Spondyloarthritis (pSpA).

Phase: N/A Priority: Normal
NCT ID: NCT05206591 Org: User:
Start: 08/16/22 End: 06/12/28 Due: 06/12/29

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

Phase: N/A Priority: Normal
NCT ID: NCT05755386 Org: User:
Start: 10/02/23 End: 05/29/29 Due: 05/29/30

A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation

Phase: N/A Priority: Normal
NCT ID: NCT01682863 Org: User:
Start: 10/31/12 End: 06/30/14 Due: 06/30/15

The Belgian REAL (BE.REAL) Registry

Phase: N/A Priority: Normal
NCT ID: NCT05726838 Org: User:
Start: 04/15/22 End: 07/01/26 Due: 07/01/27

A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®

Phase: N/A Priority: Normal
NCT ID: NCT05217810 Org: User:
Start: 05/09/22 End: 12/23/26 Due: 12/23/27

ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients

Phase: N/A Priority: Normal
NCT ID: NCT06345157 Org: User:
Start: 07/30/24 End: 06/30/26 Due: 06/30/27

Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria

Phase: N/A Priority: Normal
NCT ID: NCT04747613 Org: User:
Start: 07/27/21 End: 10/19/27 Due: 10/19/28

Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00445068 Org: User:
Start: 04/16/07 End: 12/25/09 Due: 12/25/10

Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen

Phase: N/A Priority: Normal
NCT ID: NCT04940065 Org: User:
Start: 06/30/21 End: 12/12/24 Due: 12/12/25